‘Analysis Suggests mRNA Vaccines Are Likely Cause of Reported Deaths, Spontaneous Abortions, Anaphylactic Reactions, Cardiovascular, Neurological, and Immunological Adverse Events’

By Mordechai Sones
Global Research, May 20, 2021
America's Frontline Doctors 19 May 2021
Region:
Theme:

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version). 

Visit and follow us on Instagram at @crg_globalresearch.

***

This is a summary of a study by Dr. Jessica Rose, PhD, MSc. BSC, recently completed, submitted for publication, and accepted, entitled: A report on the U.S. Adverse Events Reporting System (VAERS) of the COVID-19 Messenger RNA (mRNA) biologicals.

The goal is make the public aware of the soaring Adverse Event reports in the context of the COVID-19 biologicals being administered en-masse prior to scientifically respectable safety and efficacy studies being completed.

The study concludes:

“This work summarizes VAERS data to date and serves as information for the public and a reminder of the relevance of any adverse events, including deaths, that likely occurred as a direct result of vaccine administration.

“Based on analysis of the VAERS numbers, it may appear that AEs are not currently imposing a significant burden on the fully vaccinated population; however, the weekly releases of VAERS data do not include all of there reports made to date — they are all the reports the CDC has processed to date — and the backlog is likely to be staggering.

“Thus, due to both the problems of under-reporting and the lag in report processing, this analysis reveals a strong signal from the VAERS data that the risk of suffering an SAE following injection is significant and that the overall risk signal is high.

“Analysis suggests that the vaccines are likely the cause of reported deaths, spontaneous abortions, and anaphylactic reactions in addition to cardiovascular, neurological and immunological AEs.

“Based on the precautionary principle, since there is currently no precedent for predictability with regards to long-term effects from mRNA injections, extreme care should be taken when making a decision to participate in this experiment. mRNA platforms are new to humans with regard to mass injection programs in the context of viruses. There is currently no way to predict potential detrimental outcomes with regards to SAE occurrences in the long-term. Also, with regards to short-term analysis, this data is limited based on reporting that likely significantly underestimates actual events.”

*

Note to readers: Please click the share buttons above or below. Follow us on Instagram, @crg_globalresearch. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Featured image is from America’s Frontline Doctors
Articles by: Mordechai Sones

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]